Skip to content

Evercore

US · EVR #1462 by market cap Listed 1970
267.26 -0.82 -0.31%
Live - 5344 symbols - heartbeat 226s ago · 2026-10-08 08:21
Pre-market 263.10 -1.56%
After-hours 267.26 0.00%
Overnight 265.04 -0.83%
Market cap
10.28B
P/B
5.53
EPS
14.05
Reader sentiment Are you bullish or bearish on EVR?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 4 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.4 percentage points.

Institutional ownership

Held by institutions
94.59% -0.40pp
Institutions
800 -4
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund75.77%
Hedge Fund11.00%
Individual/Insider5.08%
Public Company2.85%
Government Pension Fund2.16%
Sovereign Wealth Fund1.09%
Private Company0.81%
Family Office/Trust0.34%
Insurance Company0.34%
Other0.56%

Top holders as of 2026-06-30

BlackRock 9.66% · 3.72M sh
Vanguard Portfolio Management, LLC 5.09% · 1.96M sh
Vanguard Capital Management, LLC 5.00% · 1.92M sh
AQR Capital Management 4.40% · 1.69M sh
State Street Global Advisors 3.14% · 1.21M sh
Edward Hyman 3.08% · 1.18M sh
Invesco Ltd. 3.05% · 1.17M sh
FMR 2.92% · 1.12M sh
Geode Capital Management, LLC 2.86% · 1.10M sh
Millennium Management LLC 1.75% · 671.92K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 26 buys · 22 sells

NameRoleStake
Edward Hyman Founder, Vice Chairman and Chairman & Head of Economic Research of Evercore ISI 3.08%
John Weinberg Chairperson & CEO 1.49%
Robert Millard Independent Director 0.13%
Gail Harris Lead Independent Director 0.10%
Roger Altman Founder & Senior Chairman 0.07%
Willard Overlock Independent Director 0.04%
Sarah Williamson Independent Director 0.03%
William Wheeler Independent Director 0.03%
Matthew Lindsey-Clark CEO of EMEA Advisory, Global Advisory Europe & Senior MD 0.03%
Simon Robertson Independent Director 0.02%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-06-10 Timothy LaLonde Senior MD & Chief Financial Officer Open Market Disposition -7,808 $343.06
2026-06-09 Ellen Futter Independent Director Other Acquisition +364 --
2026-06-09 Willard Overlock Independent Director Other Acquisition +727 --
2026-06-09 Robert Millard Independent Director Other Acquisition +815 --
2026-06-09 Christine Varney Director Other Acquisition +727 --
2026-06-09 Simon Robertson Independent Director Other Acquisition +364 --
2026-06-09 William Wheeler Independent Director Other Acquisition +364 --
2026-06-09 Pamela Carlton Independent Director Other Acquisition +364 --
2026-06-09 Gail Harris Lead Independent Director Other Acquisition +364 --
2026-06-09 Sarah Williamson Independent Director Other Acquisition +727 --
2026-05-03 Roger Altman Founder & Senior Chairman Intent to Sell (Form 144) -20,000 $316.30
2026-03-05 Sarah Williamson Independent Director Open Market Acquisition +2,000 $290.43
2026-02-28 Christine Varney Director Initial Statement of Beneficial 0 --
2026-02-18 Roger Altman Founder & Senior Chairman Other Acquisition +30,062 --
2026-02-18 Matthew Lindsey-Clark CEO of EMEA Advisory, Global Advisory Europe & Senior MD Other Acquisition +7,638 --
2026-02-18 Timothy LaLonde Senior MD & Chief Financial Officer Other Acquisition +12,465 --
2026-02-18 John Weinberg Chairperson & CEO Other Acquisition +31,528 --
2026-02-18 Paul Pensa Senior MD, Co-Director of Global Finance, Principal Accounting Officer & Controller Other Acquisition +1,867 --
2026-02-18 Jason Klurfeld Senior MD, Corporate Secretary & General Counsel Other Acquisition +8,799 --
2026-02-12 Jason Klurfeld Senior MD, Corporate Secretary & General Counsel Sale to Issuer -374 $328.56

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 08:21:30 · For reference only, not investment advice and not tailored to your situation.